MDLN - Comprehensive Filing Intelligence

FY 2025•10-K•Filed Feb 25, 2026
5.0/10
Filing Health:CAUTION

Notable concerns that warrant closer review

Executive Summary

Significant unconditional purchase obligations totaling $849 million over the next five years and beyond.. Consolidated net sales increased by 11.5% to $28.4 billion. See detailed pass outputs for comprehensive analysis.

Top Concerns

  • !Gross profit margin declined by 0.9 percentage points due to higher import costs from tariffs and initial lower margins from new Prime Vendor customers.
  • !Significant judgment in estimating variable consideration for revenue recognition (rebates, chargebacks, returns).
  • !Large amounts of goodwill and intangible assets resulting from acquisitions, with fair value estimates considered Level 3 measurements.
  • !Significant unconditional purchase obligations totaling $849 million over the next five years and beyond.
  • !A substantial $3,542 million liability under a Tax Receivable Agreement with pre-IPO owners represents a significant future cash outflow.

Top Positives

  • +Revenue grew by 11.5% driven by volume increases and acquisitions, with minimal impact from pricing.
  • +Operating expenses increased by 10.1% driven by investments in headcount, acquisitions, and higher distribution/marketing costs.
  • +Net income decreased by 3.6% mainly due to a significant increase in the provision for income taxes.

Analysis Dimensions

Our 5-pass AI analysis examines this filing across multiple dimensions. Each dimension score is derived from direct analysis of SEC filing text.

Narrative Intelligence

6.0/10

Management tone is confidently optimistic with focus on negative impact from sales to new prime vendor customers with lower initial margins..

Full analysis includes: tone changes vs prior quarter, margin driver breakdown, forward guidance analysis, strategic priorities.

Accounting Quality

6.0/10

Earnings quality shows moderate accounting practices.

Full analysis includes: reserve and allowance changes, non-recurring item analysis, stock-based compensation impact, disclosure concerns.

Hidden Liabilities

Off-balance sheet risk is moderate with $849 million in identified exposure.

Full analysis includes: cloud and purchase commitments, VIE/SPE exposure, covenant compliance status, refinancing risk assessment.

Risk Landscape

3.0/10

Overall risk profile shows regulatory compliance and enforcement as primary concern.

Full analysis includes: 8 risk categories with severity, new vs escalated risks, management response assessment, risk trend analysis.

Segment Performance

7.0/10

Segment health analysis shows Supply Chain Solutions Segment as strongest performer while Medline Brand Segment lags.

Full analysis includes: segment-by-segment revenue breakdown, geographic concentration risk, customer concentration analysis, segment margin trends.

Related Research

Analysis

MRNA 10-K Analysis: The 78% Margin Platform Hidden Behind -158% Operating Losses

Analysis

MDLN 10-K Analysis: Why Medline's Growth Story Is a Leveraged Margin Trap